Company / Capital Expenditures
Becton Dickinson Capital Expenditures History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Capital Expenditures
$760.0M
FY2025
5-year range
$725.0M / $1.2B
FY2021-FY2025
Trend
+4.8%
vs FY2024
Sector context
#14 of 151
Health Care
What the data says
Among 151 Health Care companies, Becton Dickinson is in the top 9% for capital expenditures. Capital Expenditures returned to growth in FY2025 after 3 years of decline, reaching $760M.
Based on SEC 10-K filings.
$760M in FY2025 with a 5-year CAGR of -0.2%. Top quartile in the Health Care sector.
Declined from $874M to $760M over the past 2 years.
Health Care sector context is included.
Capital Expenditures over time
Growth rates
- 3-Year CAGR
- -7.9%
- 5-Year CAGR
- -0.2%
- 10-Year CAGR
- -
Sector benchmark
Top 9% in Health CareTop 9% of 151This company $760.0M Sector average $271.7M
▼
+179.8% above sector average
Key checks
Key Insights
- 5-year CAGR of -0.2%, indicating a declining trend.
- In FY2025, capital expenditures increased 4.8% year-over-year.
- Ranks #14 out of 151 companies in the Health Care sector.
- Peak capital expenditures was recorded in FY2021.
Company context
Key Data Points
- Altman Z-Score 1.16 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Capital ExpendituresValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $760.0M | +4.8% |
| FY2024 | $725.0M | -17.0% |
| FY2023 | $874.0M | -10.2% |
| FY2022 | $973.0M | -18.5% |
| FY2021 | $1.2B | +55.3% |
| FY2020 | $769.0M | -19.6% |
| FY2019 | $957.0M | +6.9% |
| FY2018 | $895.0M | +23.1% |
| FY2017 | $727.0M | +4.9% |
| FY2016 | $693.0M | +16.3% |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026